{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:11:47Z","timestamp":1767046307976,"version":"3.40.5"},"reference-count":66,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Sociology Health &amp;amp; Illness"],"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The power of social actors to drive or block pharmaceutical uptake has been a concern in sociological debates on pharmaceuticalisation, including in the case of pandemic vaccination. We build on Steven Lukes\u2019 three\u2010dimensional view of power to explore the 2009 H1N1 pandemic vaccination in Sweden and Denmark \u2013 two similar countries that arrived at conflicting vaccination strategies. Drawing on interviews with members of each country's pandemic steering group and on document analysis, we explore three consecutive stages of pandemic vaccination response: planning, vaccine procurement and the vaccination campaign. The paper makes two contributions to studies of pharmaceuticalisation and pandemics. Conceptually, we advocate the suitability of Lukes\u2019 framework over the \u2018countervailing powers\u2019 framework repeatedly used to model power in the pharmaceutical field. Empirically, our study confirms that government\u2010appointed experts steered pandemic planning in both countries, but we show that the state, industry and the <jats:styled-content style=\"fixed-case\">WHO<\/jats:styled-content> also exerted power by enabling and constraining experts\u2019 decision\u2010making, including by keeping some information secret. Furthermore, we argue that mass vaccination in Sweden was a pervasive expression of state power, in Lukes\u2019 sense, since it rested on keeping latent the tension between many individuals\u2019 health interests and the state's interests in protecting social and economic functioning.<\/jats:p>","DOI":"10.1111\/1467-9566.13006","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T06:49:09Z","timestamp":1570776549000},"page":"327-341","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Revisiting the pharmaceuticalisation of pandemic influenza using Lukes\u2019 framework of power"],"prefix":"10.1111","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8773-9796","authenticated-orcid":false,"given":"Shai","family":"Mulinari","sequence":"first","affiliation":[{"name":"Department of Sociology Lund University Lund Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-8182","authenticated-orcid":false,"given":"Andreas","family":"Vilhelmsson","sequence":"additional","affiliation":[{"name":"Department of Sociology Lund University Lund Sweden"},{"name":"Division of Social Medicine and Global Health Department of Clinical Sciences Malm\u00f6 Lund University Malm\u00f6 Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0306312713492559"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2008.01101.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-2009-032"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0038038510369368"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.2307\/1952568"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11077-016-9264-y"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/padm.12244"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/13501763.2016.1170192"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1108\/DPM-05-2012-0060"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2012.04.002"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2012.09.004"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0038038506062034"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2009.10.068"},{"volume-title":"Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis","year":"2006","author":"Charmaz K.","key":"e_1_2_7_15_1"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.4135\/9781446279267"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.16.30208"},{"volume-title":"Who Governs? Democracy and Power in an American City","year":"2005","author":"Dahl R.A.","key":"e_1_2_7_18_1"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2011.02.035"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1057\/9781137349477"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/1467-9566.12056"},{"volume-title":"Who Rules America? Power and Politics","year":"2002","author":"Domhoff G.W.","key":"e_1_2_7_22_1"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.086173"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3948"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2014.04.035"},{"volume-title":"The 2009 A(H1N1) Pandemic in Europe","year":"2010","author":"European Centre for Disease Prevention and Control","key":"e_1_2_7_26_1"},{"key":"e_1_2_7_27_1","unstructured":"European Medicines Agency(2011)Pandemic report and lessons learned. Outcome of the European Medicines Agency's activities during the 2009 (H1N1) flu pandemic EMA\/221017\/2011.London:EMA."},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12391"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a114471"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3057"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2012.09.009"},{"volume-title":"American Capitalism: The Concept of Countervailing Power","year":"1952","author":"Galbraith J.","key":"e_1_2_7_32_1"},{"volume-title":"Pandemin som kom av sig: Om Svininfluensan i Medier och Opinion. Report","year":"2010","author":"Ghersetti M.","key":"e_1_2_7_33_1"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/1363459307083700"},{"key":"e_1_2_7_35_1","unstructured":"H\u00f8berg J. (2009)Influenzavaccination p\u00e5 eget ansvar. Jyllandsposten. 11 November. Available athttps:\/\/jyllands-posten.dk\/indland\/ECE4264414\/Influenzavaccination-p%C3%A5-eget-ansvar\/(Last accessed 21 December 2018)."},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.7765\/9781526110916"},{"issue":"1","key":"e_1_2_7_37_1","first-page":"3","article-title":"Countervailing, conditioned, and contingent \u2010 the power theory of John Kenneth Galbraith","volume":"28","author":"Kesting S.","year":"2005","journal-title":"Journal of Post Keynesian Economics"},{"key":"e_1_2_7_38_1","first-page":"25","volume-title":"Health Professions and the State in Europe","author":"Light D.W","year":"1995"},{"key":"e_1_2_7_39_1","unstructured":"Light D.W. (2013)Institutional Corruption and Countervailing Powers. 8 March. Available athttps:\/\/ethics.harvard.edu\/blog\/institutional-corruption-and-countervailing-powers(Last accessed 20 June 2019)."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-349-02248-9"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/medhum-2015-010684"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.13189\/sa.2016.041210"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2008.025361"},{"key":"e_1_2_7_44_1","unstructured":"Medical Products Agency [Sweden](2009)Sammanst\u00e4llning av inrapporterade biverkningar av Pandemrix \u2010 vaccinet mot influensa A(H1N1)v. 2 October. Available athttps:\/\/lakemedelsverket.se\/Alla-nyheter\/NYHETER-2009\/Sammanstallning-av-inrapporterade-biverkningar-av-Pandemrix\/(Lastaccessed December 21 2018)."},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.04.20064-en"},{"key":"e_1_2_7_46_1","unstructured":"Ministry of Health and Social Affairs [Sweden](2006)Klartecken till fortsatta insatser f\u00f6r att f\u00f6rverkliga produktion av influensavaccin i Sverige. Press release: 30 March. Available athttps:\/\/www.regeringen.se\/49bb54\/contentassets\/32c7ffbf05d74ac3b4ed9cd2a15a4fe1\/socialdepartementets-pressmeddelanden-2002-2006(Last accessed 21 December 2018)."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2012.01528.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-017-0259-8"},{"volume-title":"Bilag: Beredskab for Pandemic Influenza. National Strategi og Rammer for Planlaegning i Sundhedsberedskabe","year":"2006","author":"National Board of Health [Denmark]","key":"e_1_2_7_49_1"},{"key":"e_1_2_7_50_1","unstructured":"National Board of Health [Denmark](2006b)Beredskab for pandemisk influenza. National strategi og rammer for planlaegning i sundhedsberedskabe.Copenhagen Denmark."},{"key":"e_1_2_7_51_1","unstructured":"National Board of Health and Welfare [Sweden](2005)Contingency planning for an influenza pandemic: national measures.Stockholm Sweden."},{"key":"e_1_2_7_52_1","unstructured":"National Board of Health and Welfare [Sweden](2007)Agreement between GlaxoSmithKline and National Board of Health and Welfare regarding reservation guarantee and conditional supply agreement for pandemic influenza vaccine.Stockholm Sweden."},{"key":"e_1_2_7_53_1","unstructured":"National Board of Health and Welfare [Sweden](2009).Villkor i vaccinavtalen blir offentliga. 10 December. Available athttps:\/\/www.socialstyrelsen.se\/pressrum\/nyhetsarkiv\/vaccinavtal(Last accessed 21 December 2018)."},{"issue":"8","key":"e_1_2_7_54_1","first-page":"542","article-title":"Folkh\u00e4lsoministern om beredskapen \u2010 Rimligt med helt\u00e4ckande vaccination trots miljardkostnader [in Swedish]","volume":"102","author":"\u00d6rn P.","year":"2005","journal-title":"Swedish Medical Journal"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2014.06.035"},{"volume-title":"Solidarity: Reflections on an Emerging Concept in Bioethics","year":"2011","author":"Prainsack B.","key":"e_1_2_7_56_1"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151258"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494813494975"},{"volume-title":"The Pharmaceutical Studies Reader","year":"2015","author":"Sismondo S.","key":"e_1_2_7_59_1"},{"key":"e_1_2_7_60_1","unstructured":"State Serum Institute [Denmark](2006)Contract for availability of production capacity for influenza vaccine and supply in case of a pandemic between GlaxoSmithKline and Statens Serum Institut (on behalf of the Danish Government).Copenhagen Denmark."},{"key":"e_1_2_7_61_1","unstructured":"Swedish Pharmaceutical Insurer(2018)Personal communication to authors. 9 November."},{"key":"e_1_2_7_62_1","unstructured":"TT News [Sweden](2009)En miljon har vaccinerats. SVT Nyheter 27 October. Available athttps:\/\/www.svt.se\/nyheter\/inrikes\/en-miljon-har-vaccinerats(Last accessed 21 December 2018)."},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112492"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdx101"},{"key":"e_1_2_7_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2769"},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2011.01320.x"},{"volume-title":"Influenza Pandemic Preparedness Plan: The Role of WHO and Guidelines for National and Regional Planning","year":"1999","author":"World Health Organization","key":"e_1_2_7_67_1"}],"container-title":["Sociology of Health &amp; Illness"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1467-9566.13006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1467-9566.13006","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1467-9566.13006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T18:20:49Z","timestamp":1694110849000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1467-9566.13006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/1467-9566.13006"],"URL":"https:\/\/doi.org\/10.1111\/1467-9566.13006","archive":["Portico"],"relation":{},"ISSN":["0141-9889","1467-9566"],"issn-type":[{"type":"print","value":"0141-9889"},{"type":"electronic","value":"1467-9566"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"2019-10-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}